| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Net Income/ Starting Line | 7,201.00 | 6,048.50 | 3,061.40 | 2,883.50 |
| Depreciation/ Depletion | 1,470.00 | 1,250.20 | 1,165.20 | 1,228.80 |
| Non- Cash Items | -104.80 | 445.70 | 710.20 | 858.40 |
| Changesin Working Capital | -4,022.90 | -1,856.90 | -2,126.00 | -1,400.40 |
| Cashfrom Operating Activities | 4,543.30 | 5,887.50 | 2,810.80 | 3,570.30 |
| Capital Expenditures | -2,743.50 | -1,886.60 | -1,904.90 | -1,256.10 |
| Other Investing Cash Flow Items Total | -1,284.80 | -2,250.70 | -733.80 | -1,009.90 |
| Cashfrom Investing Activities | -4,028.30 | -4,137.30 | -2,638.70 | -2,266.00 |
| Financing Cash Flow Items | -226.60 | -185.30 | -134.50 | -132.10 |
| Total Cash Dividends Paid | -664.80 | -497.90 | -414.60 | -414.70 |
| Issuance( Retirement)of Stock Net | 80.50 | 36.80 | 33.40 | -92.40 |
| Issuance( Retirement)of Debt Net | 434.60 | -2,039.70 | 273.50 | 609.40 |
| Cashfrom Financing Activities | -376.30 | -2,686.10 | -242.20 | -29.80 |
| Foreign Exchange Effects | -5.90 | 28.60 | 73.30 | 11.30 |
| Net Changein Cash | 132.80 | -907.30 | 3.20 | 1,285.80 |
| Cash Interest Paid | 226.60 | 185.30 | 134.50 | 132.10 |
| Cash Taxes Paid | 2,004.70 | 1,071.40 | 743.70 | 571.60 |
Dr Reddys Laboratories Dividend Dr Reddys Laboratories Bonus Dr Reddys Laboratories News Dr Reddys Laboratories AGM Dr Reddys Laboratories Rights Dr Reddys Laboratories Splits Dr Reddys Laboratories Board Meetings Dr Reddys Laboratories Key Metrics Dr Reddys Laboratories Shareholdings Dr Reddys Laboratories Profit Loss Dr Reddys Laboratories Balance Sheet Dr Reddys Laboratories Q1 Results Dr Reddys Laboratories Q2 Results Dr Reddys Laboratories Q3 Results Dr Reddys Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks